State-Regulated Psychedelics on a Collision Course With FDA
This Viewpoint examines how US states are reforming legislation to allow access to psychedelics for therapeutic use, but federal laws consider these agents to b
Source: jamanetwork.com
Page 20 - Compass Pathways News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Compass Pathways Today - Breaking & Trending Today
First-Ever Psilocybin Clinical Trial for Treatment of Bipolar II Depression Conducted at Sheppard Pratt Reveals Promising Results
/PRNewswire/ -- JAMA Psychiatry recently published a first-of-its-kind clinical trial conducted at Sheppard Pratt studying the efficacy and safety of a single...
Source: prnewswire.com
Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry
Believed to be first ever psilocybin clinical trial for treatment of bipolar II depressionLONDON, Dec. 06, 2023 -- Compass Pathways plc , a biotechnology company dedicated to accelerating patient...
Source: marketscreener.com
Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health
Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health
Source: investorideas.com
Investor Ideas Potcasts: Interview with Kaya Holdings on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health -November 28, 2023 at 07:05 am EST
Investorideas.com, a global news source covering leading sectors including marijuana and psychedelic stocks releases a special edition of the top rated Investor Ideas potcast .In today's episode,...
Source: marketscreener.com